Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | MGAM | O43451 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | SI | P14410 | 1/20 | 0.40 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.40 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | HTR2C | P28335 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | HRH1 | P35367 | 1/20 | 0.39 |
| ▸ | DRD3 | P35462 | 1/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6515451 | 1.00 | ALDH1A1 (0.43) | ALDH1A1LMNAHSD17B10POLBALOX15 | |
| Alcohol SCHEMBL29062661 | 0.95 | ALDH1A1 (0.40) | ALDH1A1LMNAHSD17B10POLBALOX15 | |
| SCHEMBL27724226 | 0.86 | GPR84 (0.48) | ALDH1A1LMNAHSD17B10TDP1CYP3A4 | |
| SCHEMBL309000 | 0.86 | GPR84 (0.48) | ALDH1A1LMNAHSD17B10TDP1CYP3A4 | |
| SCHEMBL3019408 | 0.85 | MGAM (0.43) | ALDH1A1LMNAHSD17B10POLBMGAM | |
| SCHEMBL3019389 | 0.84 | GPR84 (0.57) | NFKB1GPR84FFAR1 | |
| SCHEMBL4644432 | 0.83 | — | — | |
| SCHEMBL4714979 | 0.83 | HDAC1 (0.39) | ALDH1A1LMNACHRM1AKR1A1CHRM3 | |
| SCHEMBL17080322 | 0.83 | ALDH1A1 (0.42) | ALDH1A1LMNAHSD17B10POLBALOX15 | |
| SCHEMBL27896646 | 0.83 | ALDH1A1 (0.42) | ALDH1A1LMNAHSD17B10POLBALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 224 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117903582-A | Full-biodegradation polylactic acid composite material and application thereof | 上海汉禾生物新材料科技有限公司 | 2024-04-19 | — | — | CN | claimed |
| CN-112543676-B | Catalyst with addition of alkyl lactate, preparation thereof and use thereof in hydrotreating and/or hydrocracking process | IFP 新能源公司 | 2024-03-01 | — | — | CN | claimed |
| CN-116693824-A | Beta-hydroxy fatty acid ester polymer and method for preparing beta-hydroxy fatty acid ester polymer by transesterification polycondensation method | 中国科学院成都有机化学有限公司 | 2023-09-05 | — | — | CN | claimed |
| US-11534742-B2 | Catalyst additivated with alkyl lactate, preparation thereof and use thereof in a hydrotreating and/or hydrocracking process | IFP Energies Nouvelles (FR) | 2022-12-27 | — | — | US | claimed |
| CN-115304516-A | Compounds with unconventional chromophores, their preparation and use | 四川大学 | 2022-11-08 | — | — | CN | claimed |
| US-20210229082-A1 | CATALYST ADDITIVATED WITH ALKYL LACTATE, PREPARATION THEREOF AND USE THEREOF IN A HYDROTREATING AND/OR HYDROCRACKING PROCESS | IFP Energies Nouvelles (FR) | 2021-07-29 | — | — | US | claimed |
| EP-3814006-A1 | CATALYST ADDITIVATED WITH ALKYL LACTATE, PREPARATION THEREOF AND USE THEREOF IN A HYDROTREATING AND/OR HYDROCRACKING PROCESS | IFP Energies nouvelles (FR) | 2021-05-05 | — | — | EP | claimed |
| CN-112543676-A | Catalyst with addition of alkyl lactate, its preparation and its use in hydrotreating and/or hydrocracking processes | IFP 新能源公司 | 2021-03-23 | — | — | CN | claimed |
| WO-2020002139-A1 | CATALYST ADDITIVATED WITH ALKYL LACTATE, PREPARATION THEREOF AND USE THEREOF IN A HYDROTREATING AND/OR HYDROCRACKING PROCESS | IFP Energies Nouvelles (FR) | 2020-01-02 | — | — | WO | claimed |
| US-8874019-B2 | Image forming method | KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) | 2014-10-28 | — | — | US | claimed |
| US-20030105100-A1 | Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity | G.D. SEARLE & CO. | 2003-06-05 | — | — | US | claimed |
| US-20030100559-A1 | Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity | G.D. SEARLE & CO. | 2003-05-29 | — | — | US | claimed |
| US-20030096818-A1 | Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity | G.D. SEARLE & CO. (US) | 2003-05-22 | — | — | US | claimed |
| US-20030087905-A1 | Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity | G.D. SEARLE & CO. | 2003-05-08 | — | — | US | claimed |
| US-20030083331-A1 | Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity | G.D. SEARLE & CO. (US) | 2003-05-01 | — | — | US | claimed |
| US-20030032644-A1 | Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity | G.D. SEARLE & CO. | 2003-02-13 | — | — | US | claimed |
| US-20020165232-A1 | Substituted N, N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity | SIKORSKI JAMES A (US) | 2002-11-07 | — | — | US | claimed |
| US-20020165231-A1 | Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity | SIKORSKI JAMES A (US) | 2002-11-07 | — | — | US | claimed |
| EP-1115693-A1 | SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY | Monsanto Company (US) | 2001-07-18 | — | — | EP | claimed |
| WO-2000018721-A1 | SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL TERTIARY-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY | MONSANTO COMPANY (US) | 2000-04-06 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030105100-A1 | Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity | CETP, MTTP, LCAT | ALDH1A1 2277/4885LMNA 1614/4885HSD17B10 374/4885 |
| US-20030096818-A1 | Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity | CETP, MTTP, LCAT | ALDH1A1 2277/4885LMNA 1614/4885HSD17B10 374/4885 |
| US-20020165231-A1 | Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity | CETP, LCAT, MTTP | ALDH1A1 2079/4885LMNA 1157/4885HSD17B10 419/4885 |
| US-20030087905-A1 | Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity | CETP, MTTP, LCAT | ALDH1A1 2277/4885LMNA 1614/4885HSD17B10 374/4885 |
| US-20030100559-A1 | Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity | CETP, MTTP, LCAT | ALDH1A1 2277/4885LMNA 1614/4885HSD17B10 374/4885 |
| US-20030083331-A1 | Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity | CETP, MTTP, LCAT | ALDH1A1 2277/4885LMNA 1614/4885HSD17B10 374/4885 |
| US-20030032644-A1 | Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity | CETP, MTTP, PCTP | ALDH1A1 2611/4885LMNA 848/4885HSD17B10 257/4885 |
| US-20020165232-A1 | Substituted N, N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity | CETP, DBI, PLTP | ALDH1A1 2588/4885LMNA 1297/4885HSD17B10 553/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.